Moberg Pharma: Interview with CEO Anna Ljung (video)

Research Interview



Redeye has interviewed CEO Anna Ljung in conjuction with the Q4 report. We discussed both the European registration and North American phase III trial as well as the upcoming events.


Mats Hyttinge

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.